Top compounds associated with response to ANKRD34C


Feature Type Standardized
Nominal ANOVA
mRNA Vandetanib FIMM pan-cancer AAC -0.28 0.1
mRNA necrostatin-1 CTRPv2 pan-cancer AAC -0.058 0.1
mRNA Nutlin-3 CCLE pan-cancer AAC -0.076 0.1
mRNA simvastatin CTRPv2 pan-cancer AAC 0.061 0.1
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.056 0.1
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.1
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.052 0.1
mRNA UNC0638 CTRPv2 pan-cancer AAC 0.055 0.1
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.052 0.1
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.054 0.1
Download CSV